Michael P. Snee

St James's Hospital
Leeds, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

A study of non small cell lung cancer (NSCLC) patients with brain metastasis: A single centre experience.

A study of non small cell lung cancer (NSCLC) patients with brain metastasis: A single centre experience.

Journal: Cancer treatment and research communications

Published: August 29, 2022

Treatment patterns and survival outcomes for patients with non-small cell lung cancer in the UK in the preimmunology era: a REAL-Oncology database analysis from the I-O Optimise initiative.

Treatment patterns and survival outcomes for patients with non-small cell lung cancer in the UK in the preimmunology era: a REAL-Oncology database analysis from the I-O Optimise initiative.

Journal: BMJ open

Published: September 16, 2021

Treatment patterns and outcomes for patients with malignant pleural mesothelioma in England in 2013-2017: A nationwide CAS registry analysis from the I-O Optimise initiative.

Treatment patterns and outcomes for patients with malignant pleural mesothelioma in England in 2013-2017: A nationwide CAS registry analysis from the I-O Optimise initiative.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: June 23, 2021

Trends in the prescription of systemic anticancer therapy and mortality among patients with advanced non-small cell lung cancer: a real-world retrospective observational cohort study from the I-O optimise initiative.

Trends in the prescription of systemic anticancer therapy and mortality among patients with advanced non-small cell lung cancer: a real-world retrospective observational cohort study from the I-O optimise initiative.

Journal: BMJ open

Published: May 04, 2021

SABRTooth: a randomised controlled feasibility study of stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I nonsmall cell lung cancer considered to be at higher risk of complications from surgical resection.

SABRTooth: a randomised controlled feasibility study of stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I nonsmall cell lung cancer considered to be at higher risk of complications from surgical resection.

Journal: The European respiratory journal

Published: January 20, 2020

Prophylactic Irradiation of Tracts in Patients With Malignant Pleural Mesothelioma: An Open-Label, Multicenter, Phase III Randomized Trial.

Prophylactic Irradiation of Tracts in Patients With Malignant Pleural Mesothelioma: An Open-Label, Multicenter, Phase III Randomized Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: March 29, 2019

18F-Fludeoxyglucose PET/CT in SCLC: Analysis of the CONVERT Randomized Controlled Trial.

18F-Fludeoxyglucose PET/CT in SCLC: Analysis of the CONVERT Randomized Controlled Trial.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: January 28, 2019

Surgery or radiotherapy for stage I lung cancer? An intention-to-treat analysis.

Surgery or radiotherapy for stage I lung cancer? An intention-to-treat analysis.

Journal: The European respiratory journal

Published: August 17, 2018

Quality of life comparing carboplatin with cisplatin in the treatment of non-small cell lung cancer.

Quality of life comparing carboplatin with cisplatin in the treatment of non-small cell lung cancer.

Journal: European journal of cancer (Oxford, England : 1990)

Published: October 11, 2017

Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial.

Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial.

Journal: The Lancet. Oncology

Published: February 28, 2017

Erratum to: The SABRTooth feasibility trial protocol: a study to determine the feasibility and acceptability of conducting a phase III randomised controlled trial comparing stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I non-small cell lung cancer (NSCLC) considered to be at higher risk of complications from surgical resection.

Erratum to: The SABRTooth feasibility trial protocol: a study to determine the feasibility and acceptability of conducting a phase III randomised controlled trial comparing stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I non-small cell lung cancer (NSCLC) considered to be at higher risk of complications from surgical resection.

Journal: Pilot and feasibility studies

Published: December 16, 2016

Longstanding Challenges in Lung Cancer: Are We Meeting Them?

Longstanding Challenges in Lung Cancer: Are We Meeting Them?

Journal: Clinical oncology (Royal College of Radiologists (Great Britain))

Published: August 02, 2016

Showing 1-12 of 23

Last Updated: 09/26/2026